Ringstad G, Emblem K E, Geier O, Alperin N, Eide P K
From the Department of Radiology and Nuclear Medicine (G.R.)
Intervention Centre (K.E.E., O.G.), Oslo University Hospital-Rikshospitalet, Oslo, Norway.
AJNR Am J Neuroradiol. 2015 Sep;36(9):1623-30. doi: 10.3174/ajnr.A4340. Epub 2015 May 14.
Aqueductal stroke volume from phase-contrast MR imaging has been proposed for predicting shunt response in normal pressure hydrocephalus. However, this biomarker has remained controversial in use and has a lack of validation with invasive intracranial monitoring. We studied how aqueductal stroke volume compares with intracranial pressure scores in the presurgical work-up and clinical score, ventricular volume, and aqueduct area and assessed the patient's response to shunting.
Phase-contrast MR imaging was performed in 21 patients with probable idiopathic normal pressure hydrocephalus. Patients were selected for shunting on the basis of pathologically increased intracranial pressure pulsatility. Patients with shunts were offered a second MR imaging after 12 months. Ventricular volume and transverse aqueductal area were calculated, as well as clinical symptom score.
No correlations between aqueductal stroke volume and preoperative scores of mean intracranial pressure or mean wave amplitudes were observed. Preoperative aqueductal stroke volume was not different between patients with shunts and conservatively treated patients (P = .69) but was correlated with ventricular volume (R = 0.60, P = .004) and aqueductal area (R = 0.58, P = .006) but not with the severity or duration of clinical symptoms. After shunting, aqueductal stroke volume (P = .006) and ventricular volume (P = .002) were reduced. A clinical improvement was seen in 16 of 17 patients who had shunts (94%).
Aqueductal stroke volume does not reflect intracranial pressure pulsatility or symptom score, but rather aqueduct area and ventricular volume. The results do not support the use of aqueductal stroke volume for selecting patients for shunting.
有人提出利用相位对比磁共振成像测量的导水管每搏量来预测正常压力脑积水患者的分流反应。然而,这种生物标志物在应用中仍存在争议,且缺乏与有创颅内监测的验证。我们研究了在术前检查中,导水管每搏量与颅内压评分、临床评分、脑室容积及导水管面积相比情况,并评估了患者对分流术的反应。
对21例可能为特发性正常压力脑积水的患者进行了相位对比磁共振成像检查。根据颅内压搏动病理性升高选择患者进行分流术。接受分流术的患者在12个月后接受第二次磁共振成像检查。计算脑室容积和导水管横截面积以及临床症状评分。
未观察到导水管每搏量与术前平均颅内压或平均波幅评分之间存在相关性。分流患者与保守治疗患者术前的导水管每搏量无差异(P = 0.69),但与脑室容积(R = 0.60,P = 0.004)和导水管面积(R = 0.58,P = 0.006)相关,而与临床症状的严重程度或持续时间无关。分流术后,导水管每搏量(P = 0.006)和脑室容积(P = 0.002)均减小。17例接受分流术的患者中有16例(94%)临床症状改善。
导水管每搏量不能反映颅内压搏动或症状评分,而是反映导水管面积和脑室容积。结果不支持使用导水管每搏量来选择分流患者。